Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
James Chih‐Hsin Yang
ResearcherPublications, citations & collaboration network
James Chih‐Hsin Yang is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,101 works, 92,257 citations, an h-index of 133 and an i10-index of 486.
1,101
Works
92,257
Citations
133
h-index
486
i10-index
How has James Chih‐Hsin Yang's publication output changed over time?
ScholarIQpublication output · 1988–2015
Output grew100% over the shown period — from 1 works in 1988 to 2 in 2015.
1
1
1
2
1
1
2
1
2
198819982002200320052006201120132015
What are the most-cited papers on James Chih‐Hsin Yang?
ScholarIQmost cited works
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler
Journal of Clinical Oncology. 20133,210 Citations
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
Science. 20022,825 CitationsOPEN ACCESS
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg
New England Journal of Medicine. 20032,707 CitationsOPEN ACCESS
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg
Science. 20062,581 CitationsOPEN ACCESS
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, Diane Solomon, Suzanne L. Topalian, Stephen T. Toy, Paul Simon, Michael T. Lotze, James Chih‐Hsin Yang, Claudia A. Seipp, Colleen Simpson, Charles W. Carter, Steven Bock, Douglas J. Schwartzentruber, John P. Wei, Donald E. White
New England Journal of Medicine. 19882,356 Citations
Related on ScholarIQ
National Taiwan University Hospital
Institution
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
Paper
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Paper
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
Paper
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Paper
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Paper